Edition:
United States

People: Ironwood Pharmaceuticals Inc (IRWD.O)

IRWD.O on Nasdaq

10.37USD
14 Jun 2019
Change (% chg)

$-0.60 (-5.47%)
Prev Close
$10.97
Open
$10.96
Day's High
$11.00
Day's Low
$10.36
Volume
733,012
Avg. Vol
1,453,744
52-wk High
$21.20
52-wk Low
$9.07

Currie, Mark 

Dr. Mark G. Currie, Ph.D. is Senior Vice President, Chief Scientific Officer, President - Research and Development, Director of the Company. He directed cardiovascular and central nervous system disease research as vice president of discovery research at Sepracor Inc. Previously, Dr. Currie initiated, built and led discovery pharmacology and also served as director of arthritis and inflammation at Monsanto Company. Dr. Currie earned a B.S. in biology from the University of South Alabama and holds a Ph.D. in cell biology from the Bowman-Gray School of Medicine of Wake Forest University.

Basic Compensation

Total Annual Compensation, USD 680,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,944,690
Fiscal Year Total, USD 2,624,690

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Peter Hecht

5,995,460

Gina Consylman

967,516

Mark Currie

2,624,690

Thomas McCourt

2,309,340

Halley Gilbert

1,933,570

Jon Duane

--
As Of  30 Dec 2017